RLAY vs. RXRX
Compare and contrast key facts about Relay Therapeutics, Inc. (RLAY) and Recursion Pharmaceuticals, Inc. (RXRX).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: RLAY or RXRX.
Correlation
The correlation between RLAY and RXRX is 0.52, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
RLAY vs. RXRX - Performance Comparison
Key characteristics
RLAY:
-0.73
RXRX:
-0.30
RLAY:
-1.31
RXRX:
0.11
RLAY:
0.86
RXRX:
1.01
RLAY:
-0.68
RXRX:
-0.31
RLAY:
-1.55
RXRX:
-0.53
RLAY:
40.80%
RXRX:
49.60%
RLAY:
86.63%
RXRX:
87.00%
RLAY:
-93.92%
RXRX:
-88.97%
RLAY:
-93.63%
RXRX:
-77.55%
Fundamentals
RLAY:
$656.14M
RXRX:
$3.63B
RLAY:
-$2.61
RXRX:
-$1.54
RLAY:
$10.01M
RXRX:
$54.29M
RLAY:
$7.24M
RXRX:
$14.55M
RLAY:
-$296.57M
RXRX:
-$262.33M
Returns By Period
In the year-to-date period, RLAY achieves a -4.85% return, which is significantly lower than RXRX's 37.28% return.
RLAY
-4.85%
-19.84%
-45.56%
-60.80%
N/A
N/A
RXRX
37.28%
23.24%
18.82%
-30.59%
N/A
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
RLAY vs. RXRX — Risk-Adjusted Performance Rank
RLAY
RXRX
RLAY vs. RXRX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Relay Therapeutics, Inc. (RLAY) and Recursion Pharmaceuticals, Inc. (RXRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
RLAY vs. RXRX - Dividend Comparison
Neither RLAY nor RXRX has paid dividends to shareholders.
Drawdowns
RLAY vs. RXRX - Drawdown Comparison
The maximum RLAY drawdown since its inception was -93.92%, which is greater than RXRX's maximum drawdown of -88.97%. Use the drawdown chart below to compare losses from any high point for RLAY and RXRX. For additional features, visit the drawdowns tool.
Volatility
RLAY vs. RXRX - Volatility Comparison
The current volatility for Relay Therapeutics, Inc. (RLAY) is 16.82%, while Recursion Pharmaceuticals, Inc. (RXRX) has a volatility of 31.65%. This indicates that RLAY experiences smaller price fluctuations and is considered to be less risky than RXRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
RLAY vs. RXRX - Financials Comparison
This section allows you to compare key financial metrics between Relay Therapeutics, Inc. and Recursion Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities